1-4 of 4
Lionel Apetoh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Feasibility and tolerability of a CD4 re-directed chimeric antigen receptor T cell therapy (CD4CAR) in hematologic malignancies: Initial Results from multi-institutional first-in-human trials

Free
Rita Assi, Amer Beitinjaneh, Emily Hopewell, Christina Vaughan, Sumeet Bhatia, Allie Carter, Jennifer Schwartz, Malak Khalife, Simpla Mahato, Lionel Apetoh, Huda Salman
Journal: Blood
Blood (2025) 146 (Supplement 1): 5947.
https://doi.org/10.1182/blood-2025-5947
Published: 2025
Journal Articles

CD4CAR T cells engage endogenous TCR to mediate antigen-independent cytotoxicity and distinct immune signatures.

Free
Dharambir Kashyap, Malak Khalife, Lionel Apetoh, Simpla Mahato, Kelvin Lee, Huda Salman
Journal: Blood
Blood (2025) 146 (Supplement 1): 7627.
https://doi.org/10.1182/blood-2025-7627
Published: 2025
Journal Articles

Phase I First-in-Human Study on the Feasibility, Safety, and Antitumor Activity of CD4-Redirected Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with CD4+ T-Cell Malignancies (TCM)

Free
Rita Assi, Nabil Hagag, Sherif Farag, Robert V.B. Emmons, Allie Carter, Magdalena Czader, Rafat Abonour, Lionel Apetoh, Yupo Ma, Huda S. Salman
Journal: Blood
Blood (2023) 142 (Supplement 1): 6854.
https://doi.org/10.1182/blood-2023-180111
Published: 2023
Journal Articles

IL-18 Elicited Suppressor NK Cells with Immunoregulatory Functions

Free
Evelyn Ullrich, MD, Magali Terme, PhD, Laetitia Aymeric, Lionel Apetoh, PhD, Nathalie Chaput, PhD, Bernhard Ryffel, PhD, Andreas Mackensen, MD, Joachim L Schultze, MD, Laurence Zitvogel, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 106.
https://doi.org/10.1182/blood.V112.11.106.106
Published: 2008